Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s12029-022-00890-4.pdf
Reference19 articles.
1. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. 2009;350(23):2335–42. https://doi.org/10.1056/NEJMoa032691.
2. Munk VC, De Miguel LS, Petrimpol M, et al. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension. 2007;[cited 2022 Jan 9];49(5):1178–85. Available from: https://doi.org/10.1161/HYPERTENSIONAHA.106.080242.
3. Si W, Xie W, Deng W, et al. Angiotensin II increases angiogenesis by NF-κB–mediated transcriptional activation of angiogenic factor AGGF1. The FASEB J 2018 [cited 2022 Jan 9];32(9):5051. Available from: https://www.pmc/articles/PMC6103173/.
4. Shen Y, Wang X, Lu J, et al. Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer. Cancer Cell. 2020;37(6):800-817.e7.
5. Chen X, Yi CH, Ya KG. Renin–angiotensin system inhibitor use and colorectal cancer risk and mortality: a dose–response meta analysis. J Renin Angiotensin Aldosterone Syst. [Internet] 2020 [cited 2022 Jan 17];21(3). Available from: https://www.pmc/articles/PMC7338647/.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer;Current Medicinal Chemistry;2024-09
2. Angiotensin converting enzyme expression on circulating immune cells from colorectal cancer patients correlates with the disease stage. Results from a preliminary study.;2024-07-26
3. Preoperative metabolic syndrome and prognosis after pancreatectomy for pancreatic cancer: A retrospective study;World Journal of Surgery;2024-07-07
4. Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap;Reports of Practical Oncology and Radiotherapy;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3